GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $228,000 | -24.8% | 650,350 | 0.0% | 0.00% | – |
| Q2 2016 | $303,000 | -58.7% | 650,350 | +20.7% | 0.00% | -100.0% |
| Q1 2016 | $733,000 | -7.4% | 538,608 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $792,000 | -6.9% | 538,608 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $851,000 | -4.7% | 538,608 | +2.5% | 0.00% | 0.0% |
| Q2 2015 | $893,000 | +45.7% | 525,274 | +19.0% | 0.00% | – |
| Q1 2015 | $613,000 | -3.3% | 441,302 | +5.1% | 0.00% | – |
| Q4 2014 | $634,000 | -31.2% | 419,829 | -6.1% | 0.00% | -100.0% |
| Q3 2014 | $921,000 | -35.8% | 447,132 | -4.6% | 0.00% | 0.0% |
| Q2 2014 | $1,434,000 | -32.1% | 468,583 | -44.5% | 0.00% | -50.0% |
| Q1 2014 | $2,112,000 | -30.6% | 844,804 | +37.7% | 0.00% | 0.0% |
| Q4 2013 | $3,042,000 | +345.4% | 613,348 | +103.8% | 0.00% | +100.0% |
| Q3 2013 | $683,000 | -4.9% | 301,013 | -6.9% | 0.00% | 0.0% |
| Q2 2013 | $718,000 | – | 323,204 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
| Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
| Matisse Capital | 17,000 | $25,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
| EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
| OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |